bpc-157 + tb4-frag bpc 157 and tb4 BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 + TB4-FRAG – Synergy

Weve reimagined traditionally delivered BPC-157 from a promising therapeutic molecule into a convenient, non-invasive and highly bioavailable solution

It's a building block for our health, involved in forming healthy red blood cells that carry oxygen throughout the body

[1] It can also be caused by acute or progressive injuries or nutritional deficiencies

In the case of IV administration, the entire dose reaches the systemic circulation and an immediate physiological response can be achieved, whereas IM and SC administrations involve an absorption process from the injection site, which leads to a delayed response, since drug molecules have to diffuse in the interstitial space in order to reach the capillaries (i.e., to be absorbed)